<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: Medical Laboratories &amp; Research Industry News</title><link>http://biz.yahoo.com/ic/news/525.html</link><description>The latest news on the Medical Laboratories &amp; Research industry from Yahoo! Finance</description><language>en-us</language><lastBuildDate>Wed, 1 Jul 2009 21:05:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>LabCorp Redeems All Outstanding Liquid Yield Option Notes Due 2021 and $369.1 Million Principal Amount at Maturity of Zero Coupon Convertible Subordinated Notes Due 2021 (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090701/20090701006243.html?.v=1</link><description>BURLINGTON, N.C.----Laboratory Corporation of AmericaÂ® Holdings announced today that it has completed the previously announced redemption of all of its outstanding zero coupon subordinated Liquid Yield Optionâ¢ Notes due 2021 and $369.1 million principal amount at maturity of its Zero Coupon Convertible Subordinated Notes due 2021 , equaling fifty percent of the principal amount at maturity outstanding of the Zero Coupon Notes.</description><guid isPermaLink="false">yahoo_finance/2658140288</guid><pubDate>Wed, 1 Jul 2009 21:05:00 Etc/GMT</pubDate></item><item><title>PPD Announces Second Quarter 2009 Earnings Release, Webcast and Conference Call (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090701/20090701005748.html?.v=1</link><description>WILMINGTON, N.C.----PPD, Inc. will release its second quarter 2009 financial results on Tuesday, July 21, 2009, after the market closes. The earnings release will be available on the PPD Web site at http://www.ppdi.com, FirstCall and Business Wire.</description><guid isPermaLink="false">yahoo_finance/1134459915</guid><pubDate>Wed, 1 Jul 2009 20:00:00 Etc/GMT</pubDate></item><item><title>LabCorp starts tender offer for Monogram shares (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090701/us_labcorp_monogram_tender_offer.html?.v=1</link><description>Laboratory Corp. of America Holdings said Wednesday it started a tender offer for Monogram Biosciences Inc., a molecular diagnostics company LabCorp agreed to buy on June 23.</description><guid isPermaLink="false">yahoo_finance/3020175271</guid><pubDate>Wed, 1 Jul 2009 14:23:15 Etc/GMT</pubDate></item><item><title>LabCorp commences tender offer for Monogram (at MarketWatch)</title><link>http://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=11kitjnkn/*http%3A//www.marketwatch.com/News/Story/Story.aspx?guid=%7b8BDC0826-362F-404E-A168-AB9F7017EC13%7d&amp;siteid=yhoof2</link><description></description><guid isPermaLink="false">yahoo_finance/1374548539</guid><pubDate>Wed, 1 Jul 2009 12:58:00 Etc/GMT</pubDate></item><item><title>LabCorp Commences Cash Tender Offer for All Outstanding Shares of Monogram Biosciences, Inc. (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090701/20090701005522.html?.v=1</link><description>BURLINGTON, N.C.----Laboratory Corporation of America® Holdings today announced the commencement of its cash tender offer for all outstanding shares of the common stock of Monogram Biosciences, Inc. for $4.55 per share.</description><guid isPermaLink="false">yahoo_finance/249160137</guid><pubDate>Wed, 1 Jul 2009 12:26:00 Etc/GMT</pubDate></item><item><title>Law Office of Brodsky &amp; Smith, LLC Announces Class Action Lawsuit Against Monogram Biosciences, Inc. (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090630/0515315.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3724224484</guid><pubDate>Tue, 30 Jun 2009 16:08:00 Etc/GMT</pubDate></item><item><title>EResearch Technology moving 30 employees from N.J. to Phila. (at bizjournals.com)</title><link>http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12kj6p1s5/*http%3A//philadelphia.bizjournals.com/philadelphia/stories/2009/06/29/daily20.html?ana=yfcpc</link><description></description><guid isPermaLink="false">yahoo_finance/3068299627</guid><pubDate>Tue, 30 Jun 2009 16:05:14 Etc/GMT</pubDate></item><item><title>Diagnostic Imaging International Corp.-CTS Sign Two New Daytime Coverage Contracts (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090630/0515276.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2391044864</guid><pubDate>Tue, 30 Jun 2009 14:17:00 Etc/GMT</pubDate></item><item><title>ERT Relocates Customer Care Team to Provide Stronger Client Support (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/090629/ph39655.html?.v=1</link><description>ERT , a leading provider of centralized ECG, ePRO, eClinical technology, and other services to the biopharmaceutical, medical device, and related industries, is to move its dedicated customer care team to its new state-of-the-art headquarters and logistics operations in Philadelphia.</description><guid isPermaLink="false">yahoo_finance/1152813047</guid><pubDate>Mon, 29 Jun 2009 19:18:00 Etc/GMT</pubDate></item><item><title>PPD Confirms Takeda Receives FDA Complete Response for Alogliptin (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090629/20090629005590.html?.v=1</link><description>WILMINGTON, N.C.----PPD, Inc. today announced that Takeda Pharmaceutical Company Limited issued a news release reporting that Takeda Global Research &amp; Development Center, Inc., its wholly-owned U.S. subsidiary, has received a complete response letter from the U.S.</description><guid isPermaLink="false">yahoo_finance/2817657216</guid><pubDate>Mon, 29 Jun 2009 12:58:00 Etc/GMT</pubDate></item><item><title>Takeda confirms delay in diabetes drug approval (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090629/us_takeda_pharma_alogliptin.html?.v=1</link><description>Japanese drugmaker Takeda Pharmaceutical Co. confirmed Monday that the U.S. Food and Drug Administration will not approve its type 2 diabetes drug candidate alogliptin without more study on its cardiovascular effects.</description><guid isPermaLink="false">yahoo_finance/838710326</guid><pubDate>Mon, 29 Jun 2009 12:02:53 Etc/GMT</pubDate></item><item><title>Micro Imaging Technology Signs Partner to Expand Sales and Manufacturing to Asia (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090629/0514599.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/4019208223</guid><pubDate>Mon, 29 Jun 2009 11:30:00 Etc/GMT</pubDate></item><item><title>Clarient Set to Join Russell 3000 Index (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/090629/la39052.html?.v=1</link><description>Clarient, Inc. , a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the Company is set to join the broad-market Russell 3000 Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indices on June 26, according to a preliminary list of additions posted June 12 on www.russell.com.</description><guid isPermaLink="false">yahoo_finance/322365845</guid><pubDate>Mon, 29 Jun 2009 10:00:00 Etc/GMT</pubDate></item><item><title>Genomic Health Inc. Needs Label Expansion (at Seeking Alpha)</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12j9f2dp3/*http%3A//seekingalpha.com/article/145536-genomic-health-inc-needs-label-expansion?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/1669300169</guid><pubDate>Fri, 26 Jun 2009 10:23:58 Etc/GMT</pubDate></item><item><title>Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/090626/sf38640.html?.v=1</link><description>Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit -</description><guid isPermaLink="false">yahoo_finance/2126397104</guid><pubDate>Fri, 26 Jun 2009 07:00:00 Etc/GMT</pubDate></item><item><title>GHDX Needs Label Expansion (Zacks.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/090625/21490.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3725690148</guid><pubDate>Thu, 25 Jun 2009 20:34:07 Etc/GMT</pubDate></item><item><title>Stem Cell Therapy International, Inc. Announces the Distribution of Histostem Products (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090625/0514120.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1250353887</guid><pubDate>Thu, 25 Jun 2009 18:01:00 Etc/GMT</pubDate></item><item><title>Ahead of the Bell: Genoptix upgraded (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090625/us_genoptix_ahead_of_the_bell.html?.v=1</link><description>An analyst for Oppenheimer and Co. upgraded shares of laboratory services company Genoptix Inc. Thursday, saying he is no longer concerned that the company is charging unsustainable fees for its cancer tests.</description><guid isPermaLink="false">yahoo_finance/3219825872</guid><pubDate>Thu, 25 Jun 2009 13:07:37 Etc/GMT</pubDate></item><item><title>Spherix diabetes drug meets midstage study goal (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090624/us_spherix_study.html?.v=1</link><description>Spherix Inc. said Wednesday its developing diabetes treatment Naturlose met its key goal of reducing glucose levels in patients.</description><guid isPermaLink="false">yahoo_finance/2128167680</guid><pubDate>Wed, 24 Jun 2009 20:32:25 Etc/GMT</pubDate></item><item><title>Spherix Announces Positive Phase 2 Study Results (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/090624/ph37686.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/121895360</guid><pubDate>Wed, 24 Jun 2009 17:25:00 Etc/GMT</pubDate></item></channel></rss><!-- c23.finance.sp1.yahoo.com compressed/chunked Sun Jul  5 12:56:59 PDT 2009 -->
